Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             51 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 An insight on how to survive COVID-19 Worrell, Rose

21 12 p. 1643
artikel
2 Antibiotics for neonatal sepsis in low-income and middle-income countries—where to go from here? Schlapbach, Luregn J

21 12 p. 1617-1618
artikel
3 An urgent need: vaccines for neglected tropical diseases Anderson, Roy M

21 12 p. 1621-1623
artikel
4 Assessing the evidence on remdesivir Trøseid, Marius

21 12 p. 1630-1631
artikel
5 Assessing the evidence on remdesivir Núñez, Isaac

21 12 p. 1630
artikel
6 Can financial rewards for stewardship in primary care curb antibiotic resistance? Lawandi, Alexander

21 12 p. 1618-1620
artikel
7 Chloroquine-resistant Plasmodium falciparum in Pakistan Khattak, Aamer Ali

21 12 p. 1632
artikel
8 Chronic cavitary pulmonary aspergillosis in an infant Liu, Zhongqiang

21 12 p. 1757
artikel
9 Chronicling PEPFAR's work in Africa Balakrishnan, Vijay Shankar

21 12 p. 1642
artikel
10 Clindamycin-resistant Streptococcus pyogenes in Chinese children Yu, Dingle

21 12 p. 1631-1632
artikel
11 Complexities in the treatment of coinfection with HIV, hepatitis B, hepatitis C, and tuberculosis Arora, Umang

21 12 p. e399-e406
artikel
12 Correction to Lancet Infect Dis 2021; 21: 929–38
21 12 p. e363
artikel
13 Correction to Lancet Infect Dis 2021; online Sept 14. https://doi.org/10.1016/S1473-3099(21)00472-2
21 12 p. e363
artikel
14 Correction to Lancet Infect Dis 2021; published online Aug 19. https://doi.org/10.1016/S1473-3099(21)00203-6
21 12 p. e363
artikel
15 Correction to Lancet Infect Dis 2021; published online Oct 28. https://doi.org/10.1016/S1473-3099(21)00648-4
21 12 p. e363
artikel
16 Correction to Lancet Infect Dis 2021; published online Oct 11. https://doi.org/10.1016/S1473-3099(21)00458-8
21 12 p. e363
artikel
17 Correction to Lancet Infect Dis 2021; published online Oct 4, https://doi.org/10.1016/S1473-3099(21)00565-X
21 12 p. e363
artikel
18 COVID-19 vaccination in pregnancy—number needed to vaccinate to avoid harm Magee, Laura A

21 12 p. 1627
artikel
19 COVID-19 vaccine intentions in Australia Pickles, Kristen

21 12 p. 1627-1628
artikel
20 COVID-19 vaccine intentions in Australia Edwards, Benjamin

21 12 p. 1628-1629
artikel
21 COVID-19 vaccines for children younger than 12 years: are we ready? Zou, Xiaohui

21 12 p. 1614-1615
artikel
22 Defeating meningitis by 2030: the WHO roadmap Venkatesan, Priya

21 12 p. 1635
artikel
23 Dismal global tuberculosis situation due to COVID-19 Bagcchi, Sanjeet

21 12 p. 1636
artikel
24 Effect of antibiotic stewardship interventions in primary care on antimicrobial resistance of Escherichia coli bacteraemia in England (2013–18): a quasi-experimental, ecological, data linkage study Aliabadi, Shirin

21 12 p. 1689-1700
artikel
25 Effect on genital warts in Australian female and heterosexual male individuals after introduction of the national human papillomavirus gender-neutral vaccination programme: an analysis of national sentinel surveillance data from 2004–18 Chow, Eric P F

21 12 p. 1747-1756
artikel
26 Effects of antibiotic resistance, drug target attainment, bacterial pathogenicity and virulence, and antibiotic access and affordability on outcomes in neonatal sepsis: an international microbiology and drug evaluation prospective substudy (BARNARDS) Thomson, Kathryn M

21 12 p. 1677-1688
artikel
27 Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM Chen, Sharon C-A

21 12 p. e375-e386
artikel
28 Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology Thompson III, George R

21 12 p. e364-e374
artikel
29 How reliable are COVID-19 burden estimates for India? Li, You

21 12 p. 1615-1617
artikel
30 Increased risk of hospitalisation and death with the delta variant in the USA Bast, Elizabeth

21 12 p. 1629-1630
artikel
31 Infectious disease surveillance update Islam, Tanzina

21 12 p. 1638
artikel
32 Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis Rustage, Kieran

21 12 p. 1701-1712
artikel
33 Investigating the origins of novel pathogens Samarasekera, Udani

21 12 p. 1633
artikel
34 Leaving—poetry is my companion Golshaie, Asal

21 12 p. 1644
artikel
35 Long-term consequences of the misuse of ivermectin data Alvarez-Moreno, Carlos

21 12 p. 1624-1626
artikel
36 Migration and outbreaks of vaccine-preventable disease in Europe: a systematic review Deal, Anna

21 12 p. e387-e398
artikel
37 Minoo Mohraz—Iran's leader in HIV research Samarasekera, Udani

21 12 p. 1640
artikel
38 Neisseria meningitidis-induced discitis at L5-S1 mimicking lumbar disc herniation Hoppe, Sven

21 12 p. 1758
artikel
39 NHS Test and Trace’s aims “overstated or not achieved” Burki, Talha

21 12 p. 1637-1638
artikel
40 Philippa Musoke—stop mother-to-child HIV transmission Kirby, Tony

21 12 p. 1641
artikel
41 Research in brief Devi, Sharmila

21 12 p. 1639
artikel
42 Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection study McCarthy, James S

21 12 p. 1713-1724
artikel
43 Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial Wu, Shipo

21 12 p. 1654-1664
artikel
44 Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial Han, Bihua

21 12 p. 1645-1653
artikel
45 SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study Laxminarayan, Ramanan

21 12 p. 1665-1676
artikel
46 Save our only planet The Lancet Infectious Diseases,

21 12 p. 1613
artikel
47 The Darwin Prospective Melioidosis Study: a 30-year prospective, observational investigation Currie, Bart J

21 12 p. 1737-1746
artikel
48 The value of open-source clinical science in pandemic response: lessons from ISARIC
21 12 p. 1623-1624
artikel
49 Towards the next generation of antimalaria combination therapies Möhrle, Jörg J

21 12 p. 1620-1621
artikel
50 Vaccination of human participants with attenuated Necator americanus hookworm larvae and human challenge in Australia: a dose-finding study and randomised, placebo-controlled, phase 1 trial Chapman, Paul R

21 12 p. 1725-1736
artikel
51 WHO recommends malaria vaccine for children Balakrishnan, Vijay Shankar

21 12 p. 1634
artikel
                             51 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland